ArticleAfrican health sciences2021

Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria.

Akinyemi Od Ofakunrin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.